Log in
Enquire now
‌

US Patent 11801288 Cancer vaccines and methods of treatment using the same

Patent 11801288 was granted and assigned to Inovio Pharmaceuticals on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Current Assignee
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11801288
Patent Inventor Names
Jian Yan
Date of Patent
October 31, 2023
Patent Application Number
17226633
Date Filed
April 9, 2021
Patent Citations
‌
US Patent 7328064 Electroporation device and injection apparatus
‌
US Patent 6939862 Method for transferring nucleic acid into striated muscles
‌
US Patent 6958060 Method for muscle delivery of drugs, nucleic acids and other compounds
‌
US Patent 7238522 Devices and methods for biomaterial production
‌
US Patent 7245963 Electrode assembly for constant-current electroporation and use
Patent Primary Examiner
‌
Meera Natarajan
Patent abstract

The invention provides a vaccine comprising a nucleic acid molecule that encodes a dog telomerase reverse transcriptase (dTERT) antigen, as well as methods of using the vaccine to induce an immune response against a TERT and to treat cancer in a mammal.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11801288 Cancer vaccines and methods of treatment using the same

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.